News

No benefit found from continuing neuroleptic drugs in Alzheimer's patients

Results of a randomised trial published in PLoS Medicine show no benefit in cognitive or neuropsychiatric outcomes from continuing neuroleptic drugs in patients with Alzheimer`s disease.